Singapore Institute of Advanced Medicine Holdings Ltd. (SG:9G2) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Singapore Institute of Advanced Medicine Holdings Ltd. is extending its strategic partnership with biotech firm EnGeneIC Pty Limited, following promising developments in EnGeneIC’s proprietary technology, the EnGeneIC Dream Vector. The companies have agreed to a 180-day extension to finalize a Definitive Agreement, with EnGeneIC bound by certain exclusivity obligations during this period. This move signifies a deepening of the collaborative efforts in the manufacturing and distribution of EDV-based products and theranostics.
For further insights into SG:9G2 stock, check out TipRanks’ Stock Analysis page.